Syngene International Ltd - 539268 - Update On Pre-Approval And Cgmp Inspection By United States Food & Drug Administration (USFDA).

Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Expensive Performer

638.3500 -2.50 (-0.39%)

NSE May 15, 2025 15:31 PM

New 52W Low in past week

Volume: 411.2K

Syngene International Ltd.

21 Feb 2025

638.35

-0.39%

Company Update

Syngene International Ltd - 539268 - Update On Pre-Approval And Cgmp Inspection By United States Food …

BSE India

Update on pre-approval and cGMP inspection by United States Food & Drug Administration (USFDA)

More from Syngene International Ltd.

Recommended

Market closes higher, Saregama India's Q4 net profit grows 11.8% YoY to Rs 60.1 crore

Trendlyne Marketwatch | 15 May 2025, 04:06PM

A car running on flat tires: Pakistan's economy is struggling

The Baseline | 15 May 2025, 09:48AM

Syngene International piles on the capex for future growth